Oncology Clinical Trials in Memphis, TN
As of August 2026, 106 paid clinical trials are recruiting for Oncology in Memphis, Tennessee. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Memphis
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
107 clinical trials for Oncology
·Clear filters·A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
GEMINI-NSCLC: NSCLC Biomarker Study
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Investigations of Reproductive Cancers in Women
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
E-Mindfulness Approaches for Living After Breast Cancer
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Project: Every Child for Younger Patients With Cancer
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Top Research Study Locations in Memphis
Researchers run research studies in Memphis, TN at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| St. Jude Children's Research Hospital | Sickle Cell Disease, Acute Lymphoblastic Leukemia, Hematologic Malignancy | 126 |
| Baptist Memorial Hospital and Cancer Center-Memphis | Anatomic Stage II Breast Cancer AJCC v8, Lung Non-Small Cell Carcinoma, Acute Myeloid Leukemia | 51 |
| Saint Jude Children's Research Hospital | Malignant Solid Neoplasm, Neuroblastoma, Acute Myeloid Leukemia Post Cytotoxic Therapy | 26 |
| Le Bonheur Children's Hospital | Congenital Heart Disease (CHD), Alagille Syndrome, Anti-myostatin | 21 |
| Baptist Cancer Center | Non-Small Cell Lung Cancer, Breast Cancer, Chronic Graft-versus-host-disease | 12 |
| Baptist Clinical Research Institute | Non-small Cell Lung Cancer, Acute Myeloid Leukemia (AML), Acute Myocardial Infarction | 9 |
| University of Tennessee Health Science Center | Aneurysm, Brain, Buccal Mucosa Squamous Cell Carcinoma, Cancer | 9 |
| Regional One Health | Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV), Burn, Cesarean Delivery | 8 |
| Baptist Memorial Hospital | Aortic Valve Disease, Aortic Valve Stenosis, Heart Disease Structural Disorder | 7 |
| LeBonheur Children's Hospital | Anesthesia, Children, Congenital Abnormalities | 6 |
| Southern College of Optometry | Amblyopia, Choroid, Intermittent Exotropia | 6 |
| Baptist Memorial Hospital for Women | Malignant Solid Neoplasm, Breast Carcinoma, Cancer | 5 |
| Clinical Neuroscience Solutions, Inc. | Major Depressive Disorder, Attention-Deficit/Hyperactivity Disorder, Chronic Migraine | 5 |
| Memphis VA Medical Center, Memphis, TN | Atherosclerosis, Chronic Kidney Disease (CKD) Stage 5, Dialysis Dependency | 4 |
| St Jude Children's Research Hospital | AML/MDS, Anesthesia, B-ALL | 4 |
| The Southern College of Optometry | Dry Eye, Presbyopia, Contact Lens Comfort | 4 |
| CNS Healthcare - Memphis | Diabetic Peripheral Neuropathic Pain, Obstructive Sleep Apnea (OSA), Proteinuric Kidney Disease | 3 |
| LifeDoc Health | Diabetes Mellitus, Type 2, Obesity, Overweight | 3 |
| Methodist Le Bonheur Healthcare | Coronary Artery Disease, Spinal Muscular Atrophy (SMA) | 3 |
| Methodist University Hospital | Intracerebral Hemorrhage, Ischemic Stroke, Atrial Fibrillation | 3 |
| Semmes Murphey Clinic | ICAD - Intracranial Atherosclerotic Disease, Intracranial Aneurysms, Ischemic Stroke | 3 |
| Baptist Cancer Center - Memphis | Colorectal Cancer, Esophageal Adenocarcinoma, Extensive-stage Small Cell Lung Cancer (ES-SCLC) | 2 |
| CNS Healthcare | Diabetes Mellitus, Type 2, Obesity, Type 2 Diabetes | 2 |
| Clinical Neuroscience Solutions Inc. | Atopic Dermatitis, Clostridoides Difficile Associated Disease | 2 |
| Clinical Neuroscience Solutions, Inc - Memphis | Chronic Idiopathic Constipation (CIC), Chronic Migraine, Episodic Migraine | 2 |
Active & Upcoming Studies in Memphis (2026)
Recruiting trials in Memphis grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (170 active studies)
- Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial) · Phase 2 · National Cancer Institute (NCI)
- Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02) · Phase 3 · Bristol-Myers Squibb
Cardiovascular (25 active studies)
- PRecision Integrated Saturation Monitor · Le Bonheur Children's Hospital
- An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients. · Phase 2 · Novartis Pharmaceuticals
Neurology & pain (22 active studies)
- Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures · Phase 4 · Azurity Pharmaceuticals
- DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea. · Phase 2 · Incannex Healthcare Ltd
Diabetes & metabolic (18 active studies)
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes · Phase 3 · Ascletis Pharma (China) Co., Limited
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities · Phase 3 · Ascletis Pharma (China) Co., Limited
Pediatric (16 active studies)
- Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma · St. Jude Children's Research Hospital
- CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma · Phase 1 · St. Jude Children's Research Hospital
HIV / STI (11 active studies)
- Combatting HIV Or Other STIs Early (CHOOSE) · Phase 2 · Westat
- Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy · International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Mental health & behavior (7 active studies)
- A Study to Evaluate the Efficacy and Safety of AXS-05 for Smoking Cessation in Adults · Phase 3 · Axsome Therapeutics, Inc.
- Feasibility of Incorporating a Standardized Substance Use Measure With Linked-Brief Intervention Into Routine Psychosocial Care of Adult Childhood Cancer Survivors · St. Jude Children's Research Hospital
Eye & vision (7 active studies)
- An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease · Phase 2 · Dompé Farmaceutici S.p.A
- A Clinical Study Evaluating Licaminlimab for Dry Eye Disease · Phase 2, Phase 3 · Oculis
Vaccines (1 active study)
Common conditions studied in Memphis
- Sickle Cell Disease (18 active studies)
- Cancer (12 active studies)
- Acute Myeloid Leukemia (9 active studies)
- Neuroblastoma (8 active studies)
- Acute Lymphoblastic Leukemia (7 active studies)
- Malignant Solid Neoplasm (7 active studies)
Leading research sponsors in Memphis
- St. Jude Children's Research Hospital
- National Cancer Institute (NCI)
- Children's Oncology Group
- SWOG Cancer Research Network
- University of Tennessee
Frequently asked questions
How many paid clinical trials are currently recruiting in Memphis?
There are approximately 455 recruiting clinical trials in Memphis, Tennessee listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Memphis pay participants?
Most recruiting trials in Memphis compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Memphis?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Memphis?
The most common conditions under active study in Memphis include Sickle Cell Disease (18), Cancer (12), Acute Myeloid Leukemia (9), Neuroblastoma (8), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Memphis?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Memphis on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Memphis?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Memphis?
Recruiting research sites in Memphis include St. Jude Children's Research Hospital, Baptist Memorial Hospital and Cancer Center-Memphis, Saint Jude Children's Research Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Memphis right now?
The largest active categories in Memphis are Cancer & tumors (170), Cardiovascular (25), Neurology & pain (22). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.